Healixia News - page 10

May 5, 2022

EU announces “A European Health Data Space for people and science” and puts patients in control of their healthdata

Today, the European Commission launched the European Health Data Space (EHDS), one of the central building blocks of a strong European Health Union. The EHDS will help the EU to achieve a quantum leap forward in the way healthcare is provided to people across Europe.

April 29, 2022

Coronavirus: monthly update of COVID-19 vaccines 28 April 2022

Coronavirus: maandelijks overzicht bijwerkingen COVID-19-vaccins van 28 april 2022

Coronavirus : aperçu mensuel des effets indésirables des vaccins contre la COVID-19 du 28 avril 2022

Source: FAMHP

April 26, 2022

Impact of war in Ukraine on clinical trials

The current war in Ukraine has had a huge impact on clinical trials in Ukraine, Russia and Belarus. Due to the war, a large number of patients in these countries participating in clinical trials are no longer able to participate. There are also problems with the supply of medicinal products and other supplies for conducting clinical trials.

Source: FAMHP

April 25, 2022

NVFG Medical Affairs Day on May 12th, 2022

NVFG (Nederlandse Vereniging van Farmaceutisch Geneeskunde) organises a full day dedicated to Medical Affairs (Veenendaal, May 12th, from 9 to 18 hrs) under the umbrella “De patiënt centraal” (the symposium will be in Dutch).

April 22, 2022

PRAC April 2022 – No causal association found between the COVID-19 vaccines Comirnaty and Spikevax and autoimmune hepatitis

During its April 2022 meeting, the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) concluded that available evidence does not support a causal link between COVID-19 vaccines Comirnaty and Spikevax and very rare cases of autoimmune hepatitis.

Source: FAMHP

April 15, 2022

IFAPP Today newsletter - April 2022

Source: IFAPP

Please find here the link to the IFAPP TODAY newsletter of April 2022.

April 14, 2022

Extension of the EU pilot project on simultaneous national scientific advice

The Head of Medicines Agencies has approved the extension of the European pilot project for simultaneous national scientific advice at its 107th meeting in February 2022. The approval followed a positive evaluation of the first results of the project since its launch in February 2020.

Source: FAMHP

April 1, 2022

Accelerated scientific-technical advice on medicines against COVID-19

Since the start of the COVID-19 health crisis, the FAMHP has given the highest priority to requests for national scientific-technical advice (STA) on medicines against COVID-19. The National Innovation Office and Scientific-Technical Advice Unit uses accelerated timelines for requests regarding medicines that prevent or cure COVID-19 infections. These timelines are crucial to support accelerated clinical research on new medicines against COVID-19.

Source: FAMHP

March 28, 2022

Coronavirus: monthly update of COVID-19 vaccines 24 March 2022

Coronavirus: maandelijks overzicht bijwerkingen COVID-19-vaccins van 24 maart 2022

Coronavirus : aperçu mensuel des effets indésirables des vaccins contre la COVID-19 du 24 mars 2022

Source: FAMHP

March 28, 2022

Genotoxic medicines and contraception: recommendations for all genotoxic active substances, regardless of therapeutic indication

The European Medicines Agency's Safety Working Party clarifies its recommendations on genotoxic medicines and the duration of contraception to apply to any genotoxic active substance, regardless of its therapeutic indication.

Source: FAMHP